| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity
|
Ahlgren, J
|
|
2002
|
38 |
1 |
p. 64-69
6 p.
|
article
|
| 2 |
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer
|
Gore, M
|
|
2002
|
38 |
1 |
p. 57-63
7 p.
|
article
|
| 3 |
Carboplatin dosing
|
Dooley, M.J
|
|
2002
|
38 |
1 |
p. 44-51
8 p.
|
article
|
| 4 |
Carboplatin dosing formulae
|
Calvert, A.H
|
|
2002
|
38 |
1 |
p. 11-16
6 p.
|
article
|
| 5 |
Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA
|
Eppler, E
|
|
2002
|
38 |
1 |
p. 184-193
10 p.
|
article
|
| 6 |
Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification
|
Kim, K
|
|
2002
|
38 |
1 |
p. 75-81
7 p.
|
article
|
| 7 |
ECCO 11—the European Cancer Conference, Lisbon, Portugal, 21–25 October 2001
|
|
|
2002
|
38 |
1 |
p. 1-5
5 p.
|
article
|
| 8 |
Estimates of cancer incidence and mortality in Europe in 1995
|
Bray, F
|
|
2002
|
38 |
1 |
p. 99-166
68 p.
|
article
|
| 9 |
Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system
|
Eggert, A
|
|
2002
|
38 |
1 |
p. 92-98
7 p.
|
article
|
| 10 |
Fatigue in cancer patients during and after treatment
|
Servaes, P
|
|
2002
|
38 |
1 |
p. 27-43
17 p.
|
article
|
| 11 |
FECS 20th Birthday—A survivor speaks
|
Horiot, Jean-Claude
|
|
2002
|
38 |
1 |
p. 8-10
3 p.
|
article
|
| 12 |
Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing
|
Léger, F.
|
|
2002
|
38 |
1 |
p. 52-56
5 p.
|
article
|
| 13 |
In vitro and in vivo activity of LS 4477 and LS 4559, novel analogues of the tubulin binder estramustine
|
Nicholson, K.M
|
|
2002
|
38 |
1 |
p. 194-204
11 p.
|
article
|
| 14 |
Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma
|
Zuzak, T.J.
|
|
2002
|
38 |
1 |
p. 83-91
9 p.
|
article
|
| 15 |
Modulation of cisplatin pharmacodynamics by Cremophor EL
|
Gelderblom, H
|
|
2002
|
38 |
1 |
p. 205-213
9 p.
|
article
|
| 16 |
[No title]
|
D'Incalci, Dr.M
|
|
2002
|
38 |
1 |
p. 17-
1 p.
|
article
|
| 17 |
[No title]
|
Smyth, J.F
|
|
2002
|
38 |
1 |
p. 7-
1 p.
|
article
|
| 18 |
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer
|
Caponigro, F
|
|
2002
|
38 |
1 |
p. 70-74
5 p.
|
article
|
| 19 |
Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil
|
Mizutani, Y
|
|
2002
|
38 |
1 |
p. 167-176
10 p.
|
article
|
| 20 |
Quality control in prophylactic mastectomy for women at high risk of breast cancer
|
Petit, J.Y.
|
|
2002
|
38 |
1 |
p. 23-26
4 p.
|
article
|
| 21 |
The use of oral cytotoxic and cytostatic drugs in cancer treatment
|
Sparreboom, A
|
|
2002
|
38 |
1 |
p. 18-22
5 p.
|
article
|
| 22 |
This issue's topics
|
|
|
2002
|
38 |
1 |
p. ix-
1 p.
|
article
|
| 23 |
Trail activity in human ovarian cancer cells
|
Vignati, S
|
|
2002
|
38 |
1 |
p. 177-183
7 p.
|
article
|
Journal description